Effects of marihuana in laboratory animals and in man.
E A Carlini, I G Karniol, P F Renault, C R Schuster
British Journal of Pharmacology February 1974 DOI: 10.1111/j.1476-5381.1974.tb08576.x (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Double-blind experimental study in animals and human subjects Peer reviewed |
|---|---|
| Sample size | 33 |
| Population | Rabbits, mice, and rats for animal tests; 33 human subjects who inhaled marijuana smoke |
| Interventions | B C) Delta(9)-tetrahydrocannabinol (Delta(9)-THC) |
| Dose | 250 mg of sample B, 500 mg of sample A, 500 mg of sample C (smoked) |
| Measures | corneal areflexia, spontaneous motor activity, catatonia, rope climbing performance, pulse rate, time production task, evaluation of psychological effects |
| Key findings | Marijuana resin potency in animal tests roughly tracked human effects: sample B (2.02% Delta(9)-THC) was most active and sample C (0.52%) was indistinguishable from placebo in people. Marijuana samples A and B produced effects two to four times greater in humans and laboratory animals than expected from their Delta(9)-THC content alone, which the authors suggest may reflect potentiation by other constituents. |
Abstract
1 The pharmacological potencies of the resins from three different samples of Brazilian marihuana (A, B and C) were determined through corneal areflexia in rabbits, decrease of spontaneous motor activity and induction of catatonia in mice, and decrease of rope climbing performance of rats.2 The Delta(9)-tetrahydrocannabinol (Delta(9) THC) content of the marihuanas, measured by gas chromatography, was 0.82, 2.02 and 0.52%, respectively, for samples A, B and C. Approximately 2% cannabinol was present in samples A and B whereas the content of cannabidiol was approximately 0.1%.3 The petroleum ether extraction of the samples A, B and C yielded, respectively, 12.06, 14.56 and 4.26% of resin.4 In all animal tests resin B was nearly twice as active as resin A, whereas C was the weakest.5 The smoke of the marihuana samples was inhaled by 33 human subjects, under a double-blind standardized procedure. Pulse rate, a time production task and an evaluation of psychological effects were recorded.6 The smoke of 250 mg of sample B provoked disruption of the time production task, increased pulse rate, and induced strong psychological reactions in four of the six subjects who received it. Similar effects, although slightly smaller, were obtained with 500 mg of sample A. On the other hand, 500 mg of sample C did not differ from placebo.7 It is suggested that it is possible by means of animal tests to predict the potency of a marihuana sample in man.8 In parallel experiments, Delta(9)-THC was administered to other human subjects and to laboratory animals in a manner similar to that in which the marihuana samples were administered.9 Comparison of the results between the marihuanas and Delta(9)-THC showed that in man and in the laboratory animals marihuanas A and B induced effects two to four times greater than expected from their Delta(9)-THC content.10 It is suggested that there may be potentiation of the effects of Delta(9)-THC by other substances present in these marihuana samples.
Citations in the library
Cited by 12
- Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties Journal of Translational Medicine October 2, 2020
- Plant and Fungal Hallucinogens as Toxic and Therapeutic Agents Plant Toxins 2019
- Clinical, Cognitive, and Neurobiological Correlates of Impaired Timing Abilities Associate to Cannabis Use: a Systematic Review International Journal of Mental Health and Addiction August 29, 2023
- Biosynthesis and synthetic biology of psychoactive natural products. Chemical Society reviews June 1, 2021
- How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review. Neuroscience & Biobehavioral Reviews September 30, 2019
and 7 more in the library